Retrieve Medical Holdings Inc (OTC:RMHI) Stock Soars 90%: What’s The Buzz?

Retrieve Medical Holdings Inc. (OTC:RMHI) is best known for having developed Retrieve Dx, a cloud-based CDI (Clinical Documentation Identity) application that helps in the improvement of physician documentation in real time. The company was in focus this past Friday after it announced that a study revealed that there had been a considerable rise in documentation diagnosis through the use of Retrieve software.

The study revealed that 10542 patent charts had been analyzed through the software. Additionally, as many as 12506 co-morbidities and diagnoses had also been discovered through the Retrieve Dx solution. In this regard, it ought to be noted that, with the push of a button, it is possible for physicians to be presented with the present co-morbidities on the computer screen of the physician. Additionally, the findings also help in including the record of the patient for more complete documentation.

The announcement made by the company was significant for two main reasons. The higher number of co-morbidity documents would have a positive influence on the CMI (Case Mix Index). The index is an important measure that provides an illustration of the complexity of the cases at any institution. Additionally, the index also has a direct impact on reimbursement levels. Another significant thing to emerge from the study was that there had been a significant reduction in the number of physician queries.

The queries often require physicians to revise and revisit patient records, which leads to additional work. Hence, there could be a reduction in disruptions to the workflow and a contribution to lower cases of burnout for physicians. The Chairman of Retrieve Medical Holdings, Dr. Mark Rosenberg, spoke about the development as well. He noted that the company’s software had performed very well and reinforced the company’s claim about the Retreive Dx application as an aid to physicians.